RT Journal Article
SR Electronic
T1 Cognitive functioning and lifetime Major Depressive Disorder in UK Biobank
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19006031
DO 10.1101/19006031
A1 L De Nooij
A1 MA Harris
A1 MJ Adams
A1 T-K Clarke
A1 X Shen
A1 SR Cox
A1 AM McIntosh
A1 HC Whalley
YR 2019
UL http://medrxiv.org/content/early/2019/09/09/19006031.abstract
AB Background The degree of cognitive impairment associated with lifetime Major Depressive Disorder (MDD) remains uncertain. Previous UK Biobank studies have only shown limited evidence for population-level cognitive differences associated with probable MDD. Here, we used an updated range of cognitive tasks and clinical assessment criteria in UK Biobank to investigate whether there are differences in cognitive function associated with lifetime MDD.Methods Associations between lifetime MDD and cognition (performance on six tasks and a general (g) factor) were investigated in UK Biobank (N range 7,457-14,836, age 45-81 years, 52% female), adjusting for demographic, education and lifestyle. Classification of lifetime MDD was based on the Composite International Diagnostic Interview (CIDI-SF). Within the lifetime MDD group, we additionally explored relationships between cognition and (i) recurrent MDD, (ii) current MDD symptoms, (iii) severity of psychosocial impairment (while symptomatic), and (iv) concurrent psychotropic medication useResults Lifetime MDD was robustly associated with a lower g-factor (β = -0.10, q = 4.7·10−5), with significant impairments in attention, processing speed and executive functioning (β ≥ 0.06). Analysis within the lifetime MDD group indicated that case individuals with severe psychosocial impairment had significantly lower g-factor (β = -0.14, P = 1.5·10−2), with greatest impairments in reasoning (β = -0.18, q = 7.5·10−5). Other clinical characteristics showed differential profiles of cognitive impairment across cognitive domains.Conclusions These findings reveal a modest negative association between lifetime MDD and cognitive performance. Specific cognitive domains showed greater deficits in relation to MDD characteristics, with greatest effects relating to psychosocial impairment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Wellcome Trust (A.M.M., grant number 104036/Z/14/Z) and the Medical Research Council (A.M.M., grant number MC_PC_17209), (S.R.C., grant numbers MR/M013111/1, MR/R024065/1).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableThis study used data from UK Biobank, a resource that is available upon registration. The dataset in the form used for the current study may be shared upon request.